We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
-5.07%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.24B
AUM Growth
-$48.8M
Cap. Flow
-$14.9M
Cap. Flow %
-0.46%
Top 10 Hldgs %
35.11%
Holding
101
New
30
Increased
21
Reduced
24
Closed
20

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$134M
2
HCA icon
HCA Healthcare
HCA
+$114M
3
AAPL icon
Apple
AAPL
+$108M
4
ELV icon
Elevance Health
ELV
+$69.3M
5
GILD icon
Gilead Sciences
GILD
+$69.3M

Top Sells

Rank Stock Value
1
AER icon
AerCap
AER
+$126M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$122M
3
SCHW
Charles Schwab
SCHW
+$91.5M
4
WBA
Walgreens Boots Alliance
WBA
+$85.3M
5
TXT icon
Textron
TXT
+$66.1M

Sector Composition

Rank Sector Weight
1 Healthcare 45.12%
2 Technology 13.88%
3 Financials 7.38%
4 Communication Services 6.63%
5 Consumer Discretionary 3.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RAD
51
DELISTED
Rite Aid Corporation
RAD
$15.4M 0.47%
94,408
-2,465
-3% -$389K
HDP
52
DELISTED
Hortonworks, Inc.
HDP
$15.3M 0.47%
1,355,970
+252,093
+23% +$2.95M
KITE
53
DELISTED
Kite Pharma, Inc.
KITE
$14.4M 0.44%
313,765
-242,668
-44% -$11.8M
MKTX icon
54
MarketAxess Holdings
MKTX
$4.34B
$13.1M 0.4%
+105,161
New +$12M
AET
55
DELISTED
Aetna Inc
AET
$12.8M 0.4%
114,231
-409,109
-78% -$43.8M
DVA icon
56
DaVita
DVA
$15.4B
$12.7M 0.39%
+173,585
New +$11.7M
CBRE icon
57
CBRE Group
CBRE
$43.1B
$12.7M 0.39%
+441,779
New +$12.2M
BABA icon
58
Alibaba
BABA
$276B
$12.7M 0.39%
160,096
-891,730
-85% -$62.8M
ACOR
59
DELISTED
Acorda Therapeutics
ACOR
$12.7M 0.39%
3,986
-6,743
-63% -$28M
AMT icon
60
American Tower
AMT
$79.9B
$12.6M 0.39%
+123,422
New +$11.5M
PXD
61
DELISTED
Pioneer Natural Resource Co.
PXD
$12.5M 0.39%
+88,985
New +$11M
GBT
62
DELISTED
Global Blood Therapeutics, Inc.
GBT
$11.8M 0.36%
742,986
+38,999
+6% +$693K
DXCM icon
63
DexCom
DXCM
$28.9B
$11.6M 0.36%
682,140
-22,012
-3% -$368K
AMSG
64
DELISTED
Amsurg Corp
AMSG
$11.4M 0.35%
+152,424
New +$10.7M
CRUS icon
65
Cirrus Logic
CRUS
$6.87B
$9.73M 0.3%
+267,373
New +$8.67M
MYOK
66
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$8.19M 0.25%
764,632
+65,938
+9% +$600K
VYGR icon
67
Voyager Therapeutics
VYGR
$184M
$7.34M 0.23%
893,541
-3,093
-0.3% -$35.1K
ACHC icon
68
Acadia Healthcare
ACHC
$3.01B
$7.21M 0.22%
+130,817
New +$7.47M
SAGE
69
DELISTED
Sage Therapeutics
SAGE
$6.35M 0.2%
198,058
+157,208
+385% +$5.53M
KURA icon
70
Kura Oncology
KURA
$826M
$6.25M 0.19%
1,541,952
+47,783
+3% +$227K
JD icon
71
JD.com
JD
$42.9B
$6.11M 0.19%
+230,412
New +$6.05M
DMTX
72
DELISTED
Dimension Therapeutics, Inc
DMTX
$5.52M 0.17%
725,169
-90,190
-11% -$710K
SPNC
73
DELISTED
Spectranetics Corp
SPNC
$4.26M 0.13%
+293,580
New +$4.06M
PEN icon
74
Penumbra
PEN
$12.6B
$2.9M 0.09%
63,045
+16,514
+35% +$772K
XENT
75
DELISTED
Intersect ENT, Inc
XENT
$1.08M 0.03%
+57,089
New +$1.03M
1 2
3
4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q1 2016 Portfolio in Review

As of Q1 2016, PFM Health Sciences held 101 positions worth $3.24B, down 1.5% from $3.29B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

PFM Health Sciences's Q1 2016 filing shows 30 new, 21 increased, 24 reduced and 20 closed positions. Its largest new stake was AbbVie: 2,396,328 shares worth $137M. The largest sale was AerCap, an estimated $126M.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 48% a quarter earlier, followed by Technology and Financials.

  • PFM Health Sciences's largest Q1 2016 buy was AbbVie: 2,396,328 shares worth $137M.
  • PFM Health Sciences added most to HCA Healthcare in Q1 2016, an estimated $114M increase.
  • PFM Health Sciences's biggest Q1 2016 reduction was Walgreens Boots Alliance, cutting an estimated $85.3M.
  • PFM Health Sciences fully exited AerCap in Q1 2016, selling an estimated $126M.
  • PFM Health Sciences's ten largest holdings make up 35% of its $3.24B portfolio in Q1 2016.
  • PFM Health Sciences opened 30 new positions and closed 20 in Q1 2016.
  • PFM Health Sciences's portfolio value fell 1.5% quarter-over-quarter to $3.24B.

Based on PFM Health Sciences's 13F filing for Q1 2016, filed 16 May 2016.